Original Research

Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients

Zaidi U, Kaleem B, Borhany M, Maqsood S, Fatima N, Sufaida G, Ansari SH, Farzana T, Shamsi TS

Cancer Management and Research 2019, 11:1493-1502

Published Date: 15 February 2019